Cover Image
Market Research Report

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024

Published by MarketsandMarkets Product code 324624
Published Content info 211 Pages
Delivery time: 1-2 business days
Price
Back to Top
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024
Published: May 22, 2019 Content info: 211 Pages
Description

"The global dPCR and qPCR market is projected to grow at a CAGR of 8.8% during the forecast period."

The global dPCR and qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8% from 2019 to 2024. The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the dPCR and qPCR market along with the availability of strong financial support in the form of investments, funds, and grants. These factors are driving the growth of dPCR and qPCR market during the forecast period. However, high instrument costs-especially that of dPCR-and the technical limitations of PCR are expected to limit market growth to a certain extent.

"The qPCR reagents segment is expected to account for the largest market share of the global qPCR products and services market in 2019."

The qPCR reagents and consumables segment is expected to account for the largest share among qPCR products in 2019. The expansion of qPCR applications in the field of clinical diagnosis, forensics, and genomic research, along with the increased funding for life science research and the rising number of probe-based multiplex genetic analysis procedures, are responsible for the dominance of the qPCR reagents and consumables segment.

"Clinical applications to show the highest growth in the dPCR and qPCR applications market during the forecast period."

The clinical applications segment will show the highest growth in the dPCR and qPCR applications market during the forecast period. The growth of this segment can be attributed to factors such as the growing usage of qPCR in disease diagnosis, rising incidence of infectious and genetic diseases, and growing public emphasis on early & effective disease diagnosis & treatment. Furthermore, the technological benefits (such as high flexibility, increased device sensitivity, better precision, and absolute quantification of the target molecule) offered by dPCR over traditional disease testing techniques and the growing adoption of dPCR among hospitals & diagnostic centers are other factors driving the growth of this segment in the forecast period.

"North America to account for the largest share of the global market in 2019."

North America accounts for the largest share of the dPCR and qPCR market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of qPCR and dPCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand of dPCR and qPCR products in this region

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 45%, Tier 2 - 34%, and Tier 3 - 21%
  • By Designation: C-level 10%, Director-level 14%, and Others - 76%
  • By Region: North America - 31%, Europe - 33%, APAC - 19%, and RoW - 17%

The major players in the market include: Abbott Laboratories (US), Agilent Technologies, Inc. (US), Analytik Jena AG (Germany), Becton Dickinson and Company (US), bioMerieux S.A. (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Fluidigm Corporation (US), Merck KGaA (Germany), Promega Corporation (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (US).

Research Coverage:

This report studies the dPCR and qPCR market based on product and services, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the market, and high-growth regions, as well as their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Table of Contents
Product Code: BT 3161

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of Primaries
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 USAGE-BASED MARKET ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 GLOBAL DPCR AND QPCR MARKET OVERVIEW
  • 4.2 QPCR AND DPCR MARKET, BY REGION, 2019 VS.2024 (USD MILLION)
  • 4.3 GLOBAL QPCR AND DPCR MARKET SHARE, BY PRODUCT AND SERVICE (2019)
  • 4.4 GLOBAL QPCR MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • 4.5 GEOGRAPHICAL SNAPSHOT OF DPCR AND QPCR MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 KEY MARKET DRIVERS
      • 5.2.1.1 Rising incidences of target infectious diseases and genetic disorders
      • 5.2.1.2 Continuous technological advancements in PCR technologies
      • 5.2.1.3 Increasing investments, funds, and grants
      • 5.2.1.4 Increasing use of biomarker profiling for disease diagnostics
      • 5.2.1.5 Successful completion of the human genome project
    • 5.2.2 KEY MARKET RESTRAINTS
      • 5.2.2.1 High device costs associated with dPCR
      • 5.2.2.2 Technical limitations of qPCR and dPCR techniques
    • 5.2.3 KEY MARKET OPPORTUNITIES
      • 5.2.3.1 Growing market penetration in emerging countries
      • 5.2.3.2 Shift from plant-derived to genome-based drug discovery
    • 5.2.4 KEY MARKET CHALLENGES
      • 5.2.4.1 Adoption and implementation of MIQE guidelines
    • 5.2.5 KEY MARKET TRENDS
      • 5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices
      • 5.2.5.2 Ongoing technological integration with the PCR process

6 DPCR AND QPCR MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 QPCR PRODUCTS & SERVICES
    • 6.2.1 QPCR REAGENTS AND CONSUMABLES
      • 6.2.1.1 Global qPCR reagents and consumables market, by application
      • 6.2.1.2 Global qPCR reagents and consumables market, by end user
    • 6.2.2 QPCR INSTRUMENTS
      • 6.2.2.1 Global qPCR instruments market, by application
      • 6.2.2.2 Global qPCR Instruments Market, by End User
    • 6.2.3 QPCR SOFTWARE AND SERVICES
      • 6.2.3.1 Global qPCR software and services market, by application
      • 6.2.3.2 Global qPCR software and services market, by end user
  • 6.3 DPCR PRODUCTS & SERVICES
    • 6.3.1 DPCR INSTRUMENTS
      • 6.3.1.1 Global dPCR instruments market, by application
      • 6.3.1.2 Global dPCR instruments market, by end user
    • 6.3.2 DPCR REAGENTS AND CONSUMABLES
      • 6.3.2.1 Global dPCR reagents and consumables market, by application
      • 6.3.2.2 Global dPCR reagents and consumables market, by end user
    • 6.3.3 DPCR SOFTWARE AND SERVICES
      • 6.3.3.1 Global dPCR software and services market, by application
      • 6.3.3.2 Global dPCR software and services market, by end user

7 DPCR AND QPCR MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 QPCR APPLICATIONS
    • 7.2.1 CLINICAL APPLICATIONS
      • 7.2.1.1 Infectious disease testing
        • 7.2.1.1.1 The wide availability of qPCR assays and kits for infectious disease testing is a key factor driving market growth
      • 7.2.1.2 Oncology testing
        • 7.2.1.2.1 Advent of alternative diagnostic technologies for oncology testing to the key restraining factor
      • 7.2.1.3 Blood screening
        • 7.2.1.3.1 The advantages offered by qPCR such as the elimination of post-amplification processing and easy process automation to drive the demand for qPCR products
      • 7.2.1.4 Transplant diagnostics
        • 7.2.1.4.1 Increasing commercialization of qPCR products for transplant diagnostic to drive the market growth
      • 7.2.1.5 Other clinical applications
    • 7.2.2 RESEARCH APPLICATIONS
      • 7.2.2.1 Increase in genome-based research activity boosts the market growth
    • 7.2.3 FORENSIC APPLICATIONS
      • 7.2.3.1 Limited adoption of qPCR in underdeveloped and developing countries is expected to restrict the market growth
  • 7.3 DPCR APPLICATIONS
    • 7.3.1 CLINICAL APPLICATIONS
      • 7.3.1.1 Infectious disease testing
        • 7.3.1.1.1 Accuracy and precision of dPCR have made it a prominent tool in infectious disease testing
      • 7.3.1.2 Oncology testing
        • 7.3.1.2.1 dPCR plays a vital role in oncology testing and clinical studies
      • 7.3.1.3 Blood screening
        • 7.3.1.3.1 dPCR offers multiple advantages over traditional techniques for blood screening
      • 7.3.1.4 Transplant diagnostics
        • 7.3.1.4.1 Low market availability of dPCR products for transplant diagnostics to reflect in small share of this market segment
      • 7.3.1.5 Other clinical applications
    • 7.3.2 RESEARCH APPLICATIONS
      • 7.3.2.1 Wide usage of dPCR in genetic research is the primary driver for market growth
    • 7.3.3 FORENSIC APPLICATIONS
      • 7.3.3.1 The need to reduce the time and cost of forensic processes is a key factor driving market growth

8 DPCR AND QPCR MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 QPCR END USERS
    • 8.2.1 HOSPITALS AND DIAGNOSTIC CENTERS
    • 8.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 8.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.2.4 CLINICAL RESEARCH ORGANIZATIONS
    • 8.2.5 FORENSIC LABORATORIES
  • 8.3 DPCR END USERS
    • 8.3.1 HOSPITALS AND DIAGNOSTIC CENTERS
    • 8.3.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 8.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.3.4 CLINICAL RESEARCH ORGANIZATIONS
    • 8.3.5 FORENSIC LABORATORIES

9 DPCR AND QPCR MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US to dominate the North American dPCR and qPCR market in 2019
    • 9.2.2 CANADA
      • 9.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany to dominate the European dPCR and qPCR market
    • 9.3.2 UK
      • 9.3.2.1 Growing focus on genomics research to support market growth in the UK
    • 9.3.3 FRANCE
      • 9.3.3.1 Initiatives for developing genomic medicine to support market growth in France
    • 9.3.4 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan
    • 9.4.2 CHINA
      • 9.4.2.1 Healthcare infrastructure modernization to support market growth in China

    • 9.4.3 INDIA
      • 9.4.3.1 Presence of a large target patient population to support market growth in India
    • 9.4.4 REST OF APAC
  • 9.5 LATIN AMERICA
    • 9.5.1 BRAZIL
      • 9.5.1.1 Brazil dominated the LATAM market in 2018
    • 9.5.2 MEXICO
      • 9.5.2.1 Favorable trade agreements will support imports and improve the accessibility to dPCR and qPCR instruments in Mexico
    • 9.5.3 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 GLOBAL MARKET SHARE ANALYSIS
    • 10.2.1 GLOBAL QPCR MARKET SHARE ANALYSIS (2018)
    • 10.2.2 GLOBAL DPCR MARKET SHARE ANALYSIS (2018)
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 KEY PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (2016-2019)
    • 10.3.2 KEY PARTNERSHIPS AND COLLABORATIONS (2016-2019)
    • 10.3.3 KEY ACQUISITIONS (2016-2019)
    • 10.3.4 KEY EXPANSIONS (2016-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING
    • 10.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2018)
      • 10.4.1.1 Visionary leaders
      • 10.4.1.2 Innovators
      • 10.4.1.3 Dynamic Differentiators
      • 10.4.1.4 Emerging Companies
    • 10.4.2 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2018)
      • 10.4.2.1 Progressive Companies
      • 10.4.2.2 Starting Blocks
      • 10.4.2.3 Responsive Companies
      • 10.4.2.4 Dynamic Companies

11 COMPANY PROFILES

  • 11.1 ABBOTT LABORATORIES
    • 11.1.1 BUSINESS OVERVIEW
    • 11.1.2 PRODUCTS OFFERED
    • 11.1.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.2 AGILENT TECHNOLOGIES, INC.
    • 11.2.1 BUSINESS OVERVIEW
    • 11.2.2 PRODUCTS AND SERVICES OFFERED
    • 11.2.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.3 ANALYTIK JENA AG (A WHOLLY OWNED SUBSIDIARY OF ENDRESS+HAUSER AG)
    • 11.3.1 BUSINESS OVERVIEW
    • 11.3.2 PRODUCTS AND SERVICES OFFERED
    • 11.3.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.4 BECTON DICKINSON AND COMPANY
    • 11.4.1 BUSINESS OVERVIEW
    • 11.4.2 PRODUCTS AND SERVICES OFFERED
    • 11.4.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.5 BIOMERIEUX S.A.
    • 11.5.1 BUSINESS OVERVIEW
    • 11.5.2 PRODUCTS AND SERVICES OFFERED
    • 11.5.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.6 BIO-RAD LABORATORIES, INC.
    • 11.6.1 BUSINESS OVERVIEW
    • 11.6.2 PRODUCTS AND SERVICES OFFERED
    • 11.6.3 RECENT DEVELOPMENTS (2016-2019)
    • 11.6.4 MNM VIEW
  • 11.7 DANAHER CORPORATION
    • 11.7.1 BUSINESS OVERVIEW
    • 11.7.2 PRODUCTS OFFERED
    • 11.7.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.8 EPPENDORF AG
    • 11.8.1 BUSINESS OVERVIEW
    • 11.8.2 PRODUCTS OFFERED
    • 11.8.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.9 F. HOFFMAN-LA ROCHE LTD.
    • 11.9.1 BUSINESS OVERVIEW
    • 11.9.2 PRODUCTS AND SERVICES OFFERED
    • 11.9.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.10 FLUIDIGM CORPORATION
    • 11.10.1 BUSINESS OVERVIEW
    • 11.10.2 PRODUCTS OFFERED
    • 11.10.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.11 MERCK KGAA
    • 11.11.1 BUSINESS OVERVIEW
    • 11.11.2 PRODUCTS AND SERVICES OFFERED
    • 11.11.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.12 PROMEGA CORPORATION
    • 11.12.1 BUSINESS OVERVIEW
    • 11.12.2 PRODUCTS AND SERVICES OFFERED
    • 11.12.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.13 QIAGEN N.V.
    • 11.13.1 BUSINESS OVERVIEW
    • 11.13.2 PRODUCTS OFFERED
    • 11.13.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.14 TAKARA BIO, INC.
    • 11.14.1 BUSINESS OVERVIEW
    • 11.14.2 PRODUCTS AND SERVICES OFFERED
    • 11.14.3 RECENT DEVELOPMENTS (2016-2019)
  • 11.15 THERMO FISHER SCIENTIFIC, INC.
    • 11.15.1 BUSINESS OVERVIEW
    • 11.15.2 PRODUCTS AND SERVICES OFFERED
    • 11.15.3 RECENT DEVELOPMENTS (2016-2019)
    • 11.15.4 MNM VIEW

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL DPCR AND QPCR MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 2: GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 3: QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 4: QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 6: GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 7: QPCR INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: GLOBAL QPCR INSTRUMENTS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 9: GLOBAL QPCR INSTRUMENTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 10: QPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 12: GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 13: GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 14: DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: DPCR INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: GLOBAL DPCR INSTRUMENTS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 17: GLOBAL DPCR INSTRUMENTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 18: DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 20: GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 21: DPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 23: GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 24: GLOBAL QPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 25: GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 26: QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: GLOBAL DPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 35: GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 36: DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44: GLOBAL QPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 45: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 46: QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 49: QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: GLOBAL DPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 51: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 52: DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53: DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 54: DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 55: DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 56: DPCR AND QPCR MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 60: NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 61: NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 62: NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: QPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 64: NORTH AMERICA: DPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: US: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 66: US: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 67: CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 69: EUROPE: QPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 70: EUROPE: DPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 71: EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 73: EUROPE: QPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 74: EUROPE: DPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 75: EUROPE: QPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 76: EUROPE: DPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77: GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 78: GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 79: UK: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 80: UK: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 81: FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 82: FRANCE: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 83: ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 84: ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 85: APAC: QPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 86: APAC: DPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 87: ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 88: ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 89: ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 90: ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 91: ASIA PACIFIC: QPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 92: ASIA PACIFIC: DPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 93: JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 94: JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 95: CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 96: CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 97: INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 98: INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 99: ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 100: ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 101: LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 102: LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 103: LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 104: LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 105: LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 106: LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 107: LATIN AMERICA: QPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 108: LATIN AMERICA: DPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 109: BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 110: BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 111: MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 112: MEXICO: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 113: ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 114: ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 115: MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 116: MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 117: MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 118: MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 119: MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 120: MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL DPCR AND QPCR MARKET
  • FIGURE 4: DATA TRIANGULATION
  • FIGURE 5: GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2019 VS. 2024
  • FIGURE 6: GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2019 VS. 2024
  • FIGURE 7: GLOBAL QPCR MARKET, BY APPLICATION, 2019 VS. 2024
  • FIGURE 8: GLOBAL DPCR MARKET, BY APPLICATION, 2019 VS. 2024
  • FIGURE 9: APAC IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 10: RISING INCIDENCES OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH
  • FIGURE 11: NORTH AMERICA IS EXPECTED TO DOMINATE BOTH QPCR AND DPCR MARKETS DURING THE FORECAST PERIOD
  • FIGURE 12: REAGENTS AND CONSUMABLES TO HOLD THE LARGEST SHARE IN THE GLOBAL DPCR AND QPCR MARKETS IN 2019
  • FIGURE 13: INFECTIOUS DISEASE TESTING TO BE THE FASTEST GROWING APPLICATION IN QPCR MARKET DURING FORECAST PERIOD
  • FIGURE 14: ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2017
  • FIGURE 17: GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2017 VS. 2030)
  • FIGURE 18: TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY
  • FIGURE 19: REAGENTS AND CONSUMABLES SEGMENT TO DOMINATE THE QPCR PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: INSTRUMENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE DPCR PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 22: EUROPE: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 23: ASIA PACIFIC: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 24: LATIN AMERICA: DPCR AND QPCR MARKET SNAPSHOT
  • FIGURE 25: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DPCR AND QPCR MARKET, 2016-2019
  • FIGURE 26: GLOBAL QPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2018)
  • FIGURE 27: GLOBAL DPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 28: GLOBAL COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
  • FIGURE 29: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
  • FIGURE 30: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
  • FIGURE 31: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 32: ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2017)
  • FIGURE 33: BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 34: BIOMERIEUX S.A.: COMPANY SNAPSHOT (2018)
  • FIGURE 35: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 36: DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 37: EPPENDORF AG: COMPANY SNAPSHOT (2017)
  • FIGURE 38: ROCHE DIAGNOSTIC DIVISION: COMPANY SNAPSHOT (2018)
  • FIGURE 39: FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 40: MERCK KGAA: COMPANY SNAPSHOT (2018)
  • FIGURE 41: QIAGEN N.V.: COMPANY SNAPSHOT (2018)
  • FIGURE 42: TAKARA BIO, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 43: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2018)
Back to Top